UNH vs GILD
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | GILD |
|---|---|---|
| Price | $407.46 | $168.08 |
| Market cap | $365.09B | $208.48B |
| P/E ratio | 23.3 | — |
| ROE | 15.77% | -22.45% |
| Profit margin | 3.53% | -12.46% |
| Revenue growth | -0.40% | 6.80% |
| Dividend yield | 2.28% | 1.95% |
| Beta | 0.52 | 0.37 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs GILD in plain English
- UNH is the bigger company — about 1.8× the market cap of GILD.
- UNH earns a higher return on equity (16% vs -22%).
- GILD is growing revenue faster (7% vs -0%).
- UNH has the higher dividend yield (2.28% vs 1.95%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.